These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18832584)

  • 1. Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7.
    Calderon Toledo C; Rogers TJ; Svensson M; Tati R; Fischer H; Svanborg C; Karpman D
    Am J Pathol; 2008 Nov; 173(5):1428-39. PubMed ID: 18832584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine immune response to shiga-toxigenic Escherichia coli O157:H7.
    Hoffman MA; Menge C; Casey TA; Laegreid W; Bosworth BT; Dean-Nystrom EA
    Clin Vaccine Immunol; 2006 Dec; 13(12):1322-7. PubMed ID: 17050743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved host defense against septic peritonitis in mice lacking MyD88 and TRIF is linked to a normal interferon response.
    Reim D; Rossmann-Bloeck T; Jusek G; Prazeres da Costa O; Holzmann B
    J Leukoc Biol; 2011 Sep; 90(3):613-20. PubMed ID: 21628330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Construction and immunization of a enterohemorrhagic Escherichia coli O157 attenuated].
    Liu J; Sun Y; Feng SZ
    Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):211-7. PubMed ID: 17460890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice.
    Kurioka T; Yunou Y; Kita E
    Infect Immun; 1998 Apr; 66(4):1726-34. PubMed ID: 9529103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains.
    Yoshimura K; Matsui T; Itoh K
    Antonie Van Leeuwenhoek; 2010 Feb; 97(2):107-17. PubMed ID: 19911297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrets as a model system for renal disease secondary to intestinal infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli.
    Woods JB; Schmitt CK; Darnell SC; Meysick KC; O'Brien AD
    J Infect Dis; 2002 Feb; 185(4):550-4. PubMed ID: 11865409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escherichia coli O157:H7 and non-O157 Shiga toxin-producing E. coli in healthy cattle, sheep and swine herds in Northern Spain.
    Oporto B; Esteban JI; Aduriz G; Juste RA; Hurtado A
    Zoonoses Public Health; 2008; 55(2):73-81. PubMed ID: 18234025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for flagella but not intimin in the persistent infection of the gastrointestinal tissues of specific-pathogen-free chicks by shiga toxin-negative Escherichia coli O157:H7.
    Best A; La Ragione RM; Sayers AR; Woodward MJ
    Infect Immun; 2005 Mar; 73(3):1836-46. PubMed ID: 15731085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isogenic strain of Escherichia coli O157:H7 that has lost both Shiga toxin 1 and 2 genes.
    Feng P; Dey M; Abe A; Takeda T
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):711-7. PubMed ID: 11427416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7.
    Nishikawa K; Matsuoka K; Kita E; Okabe N; Mizuguchi M; Hino K; Miyazawa S; Yamasaki C; Aoki J; Takashima S; Yamakawa Y; Nishijima M; Terunuma D; Kuzuhara H; Natori Y
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7669-74. PubMed ID: 12032341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome.
    Cornick NA; Jelacic S; Ciol MA; Tarr PI
    J Infect Dis; 2002 Jul; 186(1):57-63. PubMed ID: 12089662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of enterohemorrhagic Escherichia coli O157:H7 00B015: a Shiga toxin producing but virulence-attenuated isolate.
    Wang H; Gu J; Yu S; Zhang W; Zhu Y; Zou Q; Zhu F; Mao X
    Can J Microbiol; 2010 Aug; 56(8):651-6. PubMed ID: 20725127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
    Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo.
    Miyamoto Y; Iimura M; Kaper JB; Torres AG; Kagnoff MF
    Cell Microbiol; 2006 May; 8(5):869-79. PubMed ID: 16611235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study.
    Klein EJ; Stapp JR; Clausen CR; Boster DR; Wells JG; Qin X; Swerdlow DL; Tarr PI
    J Pediatr; 2002 Aug; 141(2):172-7. PubMed ID: 12183710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.
    Zhang XH; He KW; Zhang SX; Lu WC; Zhao PD; Luan XT; Ye Q; Wen LB; Li B; Guo RL; Wang XM; Lv LX; Zhou JM; Yu ZY; Mao AH
    Vaccine; 2011 May; 29(22):3923-9. PubMed ID: 21338683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of Shiga-toxin negative Escherichia coli O157 aflagellate and intimin deficient mutants in porcine in vitro and in vivo models of infection.
    Best A; La Ragione RM; Clifford D; Cooley WA; Sayers AR; Woodward MJ
    Vet Microbiol; 2006 Mar; 113(1-2):63-72. PubMed ID: 16337755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.